Barbara Dr. Behrens

Barbara Dr. Behrens

Director Life Science and New Business Development

location of Barbara Dr. BehrensGreater Hamburg Area

Connect with Barbara Dr. Behrens to Send Message

Connect

Connect with Barbara Dr. Behrens to Send Message

Connect
  • Timeline

  • About me

    Director Clinical Concepts and Oncoloy, Market Access and Scientific Networking

  • Education

    • Universität Hohenheim

      1978 - 1985
      Promotion Dr. rer. nat. Molekularbiologie

      Diplomarbeit in Pflanzenphysiologie, Abschluss mit 1,2Doktorarbeit in Molekularbiologie, Abschluss mit suma cum laude

  • Experience

    • Sysmex Europe

      Mar 2008 - Oct 2013
      Director Life Science and New Business Development

      Aufbau und Leitung des Life Science Bereiches der Firma Sysmex in Europa als Doppelspitze mit einer Kollegin über einen Zeitraum von 6 Jahren.Leitung des Bereiches NBD um insbesondere den LS Bereich über Kooperationen und Akquisitionen auszubauen.

    • Sysmex Inostics

      Oct 2013 - Aug 2018
      Director Market Market Access OncoBEAM

      Responsibility for market access, marketing and sales in DACHDevelopment of business plans Development of market access strategies with KOLs and health insurersBuilding up a network of KLOs in oncology Development and execution of clincal studies and generation of data for clinical evidenceCooperation with Pharma

    • Sysmex Deutschland GmbH

      Aug 2018 - now
      Director Clinical Concepts and Oncolocgy

      Heading a marketing and sales teamClinical Concepts:Development of clinical evidence for innovative parameters from blood count (e.g. infectious diseases, anemiea, heart diseases)Execution of clinical studiesLiteratur search and writing of articlesDevelopment of a new KOL network with clinicians (Intensive care, anestesists etc)Preparation and execution of trainings, round tables etc.Scientific marketing of the parametersOncology:Responsibility for marketing and sales in GermanyDevelopment of the German market for Sysmex Oncology Poducts (Sentimag, OSNA, Liquid Biopsy......) Development of business plans Development of market access strategies with KOLs and health insurersBuilding up a network of KLOs in oncology Development and execution of clincal studies and generation of data for clinical evidenceCooperation with Pharma Show less

  • Licenses & Certifications

    • Dr. rer. nat.

      Uni Hohenheim